文献速递外周动脉疾病

覆膜支架联合股动脉开放修复的杂交技术治疗髂股动脉病变

A Hybrid Technique to Treat Iliofemoral Lesions Using a Covered Stent Associated with Open Femoral Repair.
PubMed 文献 · Ann Vasc Surg · 2019-12-20

单中心回顾性研究纳入32例(36条肢体)复杂髂股动脉病变患者,采用自膨式覆膜支架处理髂外动脉病变联合股总动脉开放修复的杂交技术。院内死亡率6.2%,中位随访24.1个月,1年和2年一期通畅率均为93.7%,二期通畅率均为96.7%。结论认为该杂交技术死亡率和中期通畅率可接受,但需长期随访评估安全性和耐久性。

要点

  • 杂交技术治疗复杂髂股动脉病变的院内死亡率为6.2%。
  • 1年和2年一期通畅率均为93.7%,二期通畅率均为96.7%。
  • 1年和2年免于大截肢率分别为96%和91%。

核心结论

  • 该杂交技术治疗髂股动脉病变的死亡率和中期通畅率可接受。
  • 需要进一步长期随访研究评估该技术的安全性和耐久性。

研究设计与样本

  • 单中心回顾性研究,纳入2012至2017年连续32例患者(36条肢体)。
  • 采用自膨式覆膜支架处理髂外动脉病变,联合股总动脉开放修复。

主要发现

  • 间歇性跛行13条肢体(36%),静息痛13条肢体(36%),组织缺损10条肢体(28%)。
  • 院内死亡2例(6.2%),均为老年严重肢体缺血患者。
  • 4例(12.5%)出现中重度并发症,包括1例因入院时组织缺损行胫骨截肢。
  • 中位随访24.1个月(范围0.8-64个月)。
  • 1年和2年总生存率分别为91%(95%CI:97-74)和76%(95%CI:89-53)。

关键数值与推荐

  • 1年和2年免于大截肢率分别为96%(95%CI:99-76)和91%(95%CI:97-66)。
  • 1年和2年一期通畅率均为93.7%(95%CI:77.1-98.4)。
  • 1年和2年辅助一期通畅率均为96.7%(95%CI:78.6-99.6)。
  • 1年和2年二期通畅率均为96.7%(95%CI:78.6-99.6)。

临床怎么用

  • 对于复杂髂股动脉病变,可考虑采用覆膜支架联合股动脉开放修复的杂交技术。
  • 术中支架经股动脉切开处外置并剪断,避免支架与股动脉重建之间遗留未处理过渡区。

局限性

  • 单中心回顾性研究,样本量较小(32例,36条肢体)。
  • 随访时间有限,中位24.1个月,最长64个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To describe a hybrid approach for complex iliofemoral lesions and report short-term and mid-term results. METHODS: In this single-center retrospective study, all consecutive patients (n = 32, 36 limbs) who underwent hybrid repair of complex iliofemoral lesions between 2012 and 2017 using a conformable self-expandable covered stent for external iliac artery lesions and open repair of the common femoral artery were included. Lesions were responsible for claudication in 13 (36%) limbs, rest pain in 13 (36%) limbs and tissue loss in 10 (28%) limbs. Over a wire crossing the iliac lesion, the covered stent was deployed, externalized through the femoral arteriotomy, and cut at the iliofemoral junction in such a way that no untreated transition zone remained between the stent and the open reconstruction of the femoral artery. RESULTS: Two elderly patients with critical limb ischemia died during the postoperative course, giving in-hospital mortality of 6.2%. Four (12.5%) presented with moderate to severe complications, including one transtibial amputation in a patient who presented with tissue loss at admission. The median follow-up period was 24.1 months (range: 0.8-64 months). One-year and two-year Kaplan-Meier estimates of overall survival were 91% (95% CI: 97-74) and 76% (95% CI: 89-53). One-year and two-year estimates of freedom from major amputation were 96% (95% CI: 99-76) and 91% (95% CI: 97-66). Estimates of primary patency, assisted primary patency, and secondary patency were: 93.7 (95% CI: 77.1-98.4) at 1 year, and 93.7 (95% CI: 77.1-98.4) at 2 years; 96.7% (95% CI: 78.6-99.6) at 1 year, and 96.7% (95% CI: 78.6-99.6) at 2 years; 96.7% (95% CI: 78.6-99.6) at 1 year and 96.7% (95% CI: 78.6-99.6) at 2 years, respectively. CONCLUSIONS: Our hybrid approach for iliofemoral lesions provided acceptable mortality and good mid-term patency rates. Further studies with long-term followup are needed to evaluate the safety and durability of this technique.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bosse C, Becquemin JP, Touma J, et al. A Hybrid Technique to Treat Iliofemoral Lesions Using a Covered Stent Associated with Open Femoral Repair. Ann Vasc Surg. 2019. PMID: 31866550. doi:10.1016/j.avsg.2019.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。